ORAGENICS INC | Business Contracts

Executive Employment Agreement for Ms. Huffman dated effective March 7, 2023 (Filed With SEC on March 8, 2023)

At the Market Offering Agreement dated February 24, 2023, by and among Oragenics, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on February 24, 2023)

Specimen Stock Certificate (Filed With SEC on January 23, 2023)

NRC Technology License Amendment 4 (Filed With SEC on August 9, 2022)

Amended and Restated Exclusive Channel Collaboration Agreement by and between Oragenics, Inc. and Eleszto Genetika, Inc. dated as of March 1, 2021(Lantibiotic ECC) (Filed With SEC on March 1, 2021)

Second Amendment to Lease Agreement between the Company and Hawley-Wiggins LLC dated July 13, 2014 (13700 Progress Blvd, Alachua, FL 32615) (Filed With SEC on March 4, 2020)

Executive Employment Agreement for Ms. Murphy dated June 23, 2022 (Filed With SEC on June 23, 2022)

NRC Technology License Amendment 3 (Filed With SEC on March 24, 2022)

NRC Technology License Amendment 2 (Filed With SEC on March 24, 2022)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 24, 2022)

Form Stock Option Award Agreement (Consultants) (Filed With SEC on February 28, 2022)

Form Stock Option Award Agreement (Employees) (Filed With SEC on February 28, 2022)

Form Stock Option Award Agreement (Directors) (Filed With SEC on February 28, 2022)

2021 Equity Incentive Plan (Filed With SEC on February 28, 2022)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act Of 1934 (Filed With SEC on March 1, 2021)

Sales Agent Agreement dated February 1, 2021 (Filed With SEC on February 1, 2021)

Form of Securities Purchase Agreement (Filed With SEC on December 28, 2020)

Placement Agent Agreement dated December 23, 2020 (Filed With SEC on December 28, 2020)

Underwriting Agreement dated November 19, 2020 (Filed With SEC on November 24, 2020)

Non-exclusive intellectual property and biological materials license agreement with the National Institute of Allergy and Infectious Diseases, an institute within the National... (Filed With SEC on August 14, 2020)

Second Amendment to Employment Agreement between the Company and Alan Joslyn effective June 6, 2020 (Filed With SEC on June 5, 2020)

Stock Purchase Agreement, dated May 1, 2020 (Filed With SEC on May 4, 2020)

Warrant, dated May 1, 2020 (Filed With SEC on May 4, 2020)

Form of Notice of Grant of Stock Options and Stock Option Award Agreement (Directors) (Filed With SEC on March 4, 2020)

Notice of Assignment of Lantibiotic ECC and Lantibiotic SIA by and between Oragenics, Inc. and Intrexon Corporation (n/k/a Precigen Inc.) to ILH Holdings Inc. effective January 1,... (Filed With SEC on March 4, 2020)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act Of 1934 (Filed With SEC on March 4, 2020)

Fourth Amendment to 2012 Equity Incentive Plan (Filed With SEC on June 21, 2019)

Specimen Stock Certificate (Filed With SEC on March 29, 2019)

Underwriting Agreement dated March 21, 2019 (Filed With SEC on March 25, 2019)

Form of Series 2 Warrant (Filed With SEC on March 25, 2019)

Form of Series 1 Warrant (Filed With SEC on March 25, 2019)

ORAGENICS INC (31)